Literature DB >> 2045201

Effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer activity.

I S Tunru1, H Suzuki, S Yano.   

Abstract

The enhancing effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer (LAK) activity was investigated in this study. Peritoneal macrophages significantly enhanced LAK activity generated from accessory cell-depleted splenic lymphocytes in both IL-2 and IL-4 cultures. This effect was dependent on the number of macrophages and was not replaced by a factor derived from macrophages or lymphocytes. Macrophages enhanced IL-2- and IL-4-induced LAK activity against both natural killer (NK)-sensitive (YAC-I, P388D1) and NK-resistant (P815) tumor cells. Negative selection of cells with antibodies and complement showed no differences in surface markers between IL-2 LAK effectors and IL-4 LAK effectors generated in the presence of macrophages. These results suggest that the same LAK effector subsets can be enhanced by macrophages in either IL-2 or IL-4 cultures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045201     DOI: 10.1002/ijc.2910480415

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Human recombinant IL-4 decreases the emergence of non-specific cytolytic cells and favours the appearance of memory cells (CD4+CD45RO+) in the IL-2-driven development of cytotoxic T lymphocytes against autologous ovarian tumour cells.

Authors:  A D Roth; S Dupuis; P Alberto
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

2.  CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice.

Authors:  K M Kadowaki; H Matsuno; H Tsuji; I Tunru
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

3.  Induction of lymphokine-activated killer cells from nude mouse spleen cells by interleukin-4.

Authors:  I S Tunru; H Suzuki; M Kobayashi
Journal:  Experientia       Date:  1993-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.